Wearable MRI still in the works

After leaving high-profile technology jobs with Facebook Oculus and Google X, Mary Lou Jepsen, PhD, resurfaced in September at a wearable-technology conference in Boston. She said her current company, Openwater, is forging ahead with its plan to develop wearable MRI devices that will use holograms to produce better-than-MRI-quality images at a fraction of the cost.

“Think of a rock in the middle of a shallow, circular pool with dozens of children splashing around the ring of the pool, creating ripples. Sensors in the pool measure how those ripples bounce, fragment, and scatter as they roll over the rock,” the website Quartz reports in explaining Jepsen’s vision. “By analyzing the patterns of how the ripples break and scatter against the rock, one could reconstruct what the rock looked like. That’s what Openwater wants to do but with near infrared light instead of water, and instead of imaging a rock, it’ll be imaging our bodies and our brains.”

Quartz underscores the upside from patients’ point of view: They’ll be able to trade lying motionless inside a “clicking metal coffin” for a not-unenjoyable experience wearing a special shirt or skullcap.

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.